The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growth

Irina Alimova(University of Colorado Anschutz Medical Campus), Rajeev Vibhakar(University of Colorado Denver)
Neuro-Oncology Advances
January 1, 2023
Cited by 5


Related Papers